Letko, Brosseau & Associates’s Outset Medical OM Stock Holding History

Letko, Brosseau & Associates’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-903	Closed	-$15K	–	95
2024 Q4	$15K	Hold	903	–	–	﹤0.01%	100
2024 Q3	$9.17K	Hold	903	–	–	﹤0.01%	101
2024 Q2	$52.2K	Hold	903	–	–	﹤0.01%	101
2024 Q1	$30.1K	Hold	903	–	–	﹤0.01%	100
2023 Q4	$73.3K	Hold	903	–	–	﹤0.01%	94
2023 Q3	$147K	Hold	903	–	–	﹤0.01%	89
2023 Q2	$296K	Buy	903 +146	+19%	+$44.5K	0.01%	83
2023 Q1	$209K	Hold	757	–	–	﹤0.01%	84
2022 Q4	$293K	Sell	757 -743	-50%	-$210K	0.01%	90
2022 Q3	$358K	Hold	1,500	–	–	0.01%	88
2022 Q2	$334K	Hold	1,500	–	–	0.01%	89
2022 Q1	$1.02M	Hold	1,500	–	–	0.02%	85
2021 Q4	$1.04M	Hold	1,500	–	–	0.01%	88
2021 Q3	$1.11M	Hold	1,500	–	–	0.02%	89
2021 Q2	$1.13M	Buy	+1,500	New	+$1.15M	0.02%	89

Other funds holding OM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Letko, Brosseau & Associates's OM Position: Q1 2025 in Review

Letko, Brosseau & Associates sold out of Outset Medical (OM) in Q1 2025, closing a stake of 903 shares — an estimated $15K sold.

Letko, Brosseau & Associates first reported a position in OM in Q2 2021 and held it in 15 quarters. The position peaked at $1.13M in Q2 2021. 61 funds tracked by Wall St. Rank hold OM as of Q1 2025.

Letko, Brosseau & Associates reported no remaining Outset Medical position as of Q1 2025 after selling out during the quarter.
Letko, Brosseau & Associates sold 903 Outset Medical shares in Q1 2025, an estimated $15K.
Letko, Brosseau & Associates first reported a position in Outset Medical in Q2 2021 and held it in 15 quarters.
Letko, Brosseau & Associates's Outset Medical position peaked at $1.13M in Q2 2021.
61 funds tracked by Wall St. Rank held Outset Medical as of Q1 2025.

Based on Letko, Brosseau & Associates's 13F filing for Q1 2025, filed 8 May 2025.